Tech Company Financing Transactions

Practice Fusion Funding Round

Practice Fusion, based in San Francisco, received $8.2 million from private investors.

Transaction Overview

Company Name
Announced On
1/9/2012
Transaction Type
Debt
Amount
$8,165,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing-amended.

Company Information

Company Status
Acquired or Merged
Industry
Enterprise IT
Mailing Address
420 Taylor Street
San Francisco, CA 94102
USA
Email Address
Overview
Practice Fusion addresses the critical needs of today's healthcare environments by providing a revolutionary application and delivery model for physicians and patients at no cost.
Profile
Practice Fusion LinkedIn Company Profile
Social Media
Practice Fusion Company Twitter Account
Company News
Practice Fusion News
Facebook
Practice Fusion on Facebook
YouTube
Practice Fusion on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tom Langan
  Tom Langan LinkedIn Profile  Tom Langan Twitter Account  Tom Langan News  Tom Langan on Facebook
Chief Medical Officer
Richard Loomis
  Richard Loomis LinkedIn Profile  Richard Loomis Twitter Account  Richard Loomis News  Richard Loomis on Facebook
Chief Scientific Officer
Dorothy Gemmell
  Dorothy Gemmell LinkedIn Profile  Dorothy Gemmell Twitter Account  Dorothy Gemmell News  Dorothy Gemmell on Facebook
Chief Technical Officer
Jonathan Malek
  Jonathan Malek LinkedIn Profile  Jonathan Malek Twitter Account  Jonathan Malek News  Jonathan Malek on Facebook
Co-Founder
Matthew Douglass
  Matthew Douglass LinkedIn Profile  Matthew Douglass Twitter Account  Matthew Douglass News  Matthew Douglass on Facebook
VP - General Counsel
Riyad Omar
  Riyad Omar LinkedIn Profile  Riyad Omar Twitter Account  Riyad Omar News  Riyad Omar on Facebook
VP - Product Management
Octavia Petrovici
  Octavia Petrovici LinkedIn Profile  Octavia Petrovici Twitter Account  Octavia Petrovici News  Octavia Petrovici on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/9/2012: Avaxia Biologics venture capital transaction
Next: 1/9/2012: Roka Bioscience venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary